FDA Prepping for THIS New Pandemic?!

(DailyEmailNews.com) – Raising the alarms over a new pandemic in America, the Food and Drug Administration (FDA) is proactively preparing for the potential of the current avian flu strain in the U.S. to spread massively among humans.

FDA commissioner Robert Califf reassured senators on the Senate Appropriations Committee that the risk to humans currently remains low and that dairy products are safe.

However, he emphasized that the FDA and other agencies should remain ready and mentioned that medical responses were in development.

“So we got to have testing. Gotta have antivirals, and we need to have a vaccine ready to go. So we’ve been busy, getting prepared for if the virus does mutate in a way that jumps into humans on a larger level,” Califf explained.

He outlined a scenario where the H5N1 influenza virus could potentially shift to human transmission, affect the lungs and possibly become airborne, which he described as “really bad.”

Califf restated that while the public health risk is currently low, the agency is taking precautions to avoid being unprepared.

He noted that the mortality rate among cattle is less than 1% since the virus is mostly causing mild illness.

Despite this, potential asymptomatic spread risks exist, which prompted a recommendation for dairy farm workers to use personal protective equipment (PPE).

“If we institute the countermeasures now and reduce the spread of the virus now, then we’re much less likely to see a mutation that jumps to humans for which we’re ill-prepared,” he stated.

According to the Centers for Disease Control and Prevention, the bird flu has so far affected 36 dairy cattle herds across nine states including Colorado, Idaho, Kansas, Michigan, New Mexico, North Carolina, Ohio, South Dakota and Texas.

There has been a single documented case of the flu infecting a human—a farmworker in Texas who developed conjunctivitis but has since recovered.

Califf said he was confident that vaccine production could quickly scale up if necessary by taking advantage of existing mRNA technology to adapt to new viral strains efficiently.

“We’re in an enviable position compared to any time in the history of the world,” Califf remarked. “Viruses are relatively simple, so coming up with a matching vaccine is entirely possible in a short period of time.”

Copyright 2024, DailyEmailNews.com